Prolonged Vasospasm in Subarachnoid Hemorrhage
PVE
Clinical Implication of Prolonged Vasospasm in Subarachnoid Hemorrhage
1 other identifier
observational
109
0 countries
N/A
Brief Summary
The prevalence and clinical implications of prolonged cerebral vasospasm in patients with subarachnoid hemorrhage are unknown.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2015
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2019
CompletedFirst Submitted
Initial submission to the registry
December 6, 2019
CompletedFirst Posted
Study publicly available on registry
December 10, 2019
CompletedDecember 10, 2019
December 1, 2019
3.8 years
December 6, 2019
December 6, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Clinical implication
Presence or not of neurological symptoms related to intracranial vasospasm (delayed cerebral ischemia)
1 month
Gravity of vasospasm by transcranial doppler
Mild, moderate and severe according to Aaslid scale
1 month
Secondary Outcomes (1)
Mortality assessment
six monts
Other Outcomes (1)
Neurological recovery
six monts
Study Arms (1)
Prolonged vasospasm
Adult patients with a diagnosis of subarcnoid hemorrhage CT scan or presence of blood in the cerebrospinal fluid were incorporated. Patients with vasospasm were followed daily with transcranial doppler. Prolonged vasospasm was defined for patients who persisted with vasospasm after day 21 of cerebral bleeding.
Interventions
Daily monitoring of transcranial doppler until the disappearance of the intracranial vasosparm
Eligibility Criteria
Patients with subarachnoid hemorrhage and vasospasm
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (4)
Harders AG, Gilsbach JM. Time course of blood velocity changes related to vasospasm in the circle of Willis measured by transcranial Doppler ultrasound. J Neurosurg. 1987 May;66(5):718-28. doi: 10.3171/jns.1987.66.5.0718.
PMID: 3553456RESULTMASPES PE, MARINI G. Intracranial arterial spasm related to supraclinoid ruptured aneurysms. Acta Neurochir (Wien). 1962 Dec 12;10:630-8. doi: 10.1007/BF01406192. No abstract available.
PMID: 13933363RESULTYamaguchi M, Bun T, Kuwahara T, Kitamura S. Very late-onset symptomatic cerebral vasospasm caused by a large residual aneurysmal subarachnoid hematoma--case report. Neurol Med Chir (Tokyo). 1999 Sep;39(9):677-80. doi: 10.2176/nmc.39.677.
PMID: 10563118RESULTMuller M, Schwerdtfeger K, Zieroth S. Assessment of middle cerebral artery diameter after aneurysmal subarachnoid hemorrhage by transcranial color-coded duplex sonography. Eur J Ultrasound. 2000 Mar;11(1):15-9. doi: 10.1016/s0929-8266(99)00066-x.
PMID: 10717509RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Target Duration
- 6 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of Intensive Care Unit at Hospital El Cruce
Study Record Dates
First Submitted
December 6, 2019
First Posted
December 10, 2019
Study Start
April 1, 2015
Primary Completion
January 1, 2019
Study Completion
December 1, 2019
Last Updated
December 10, 2019
Record last verified: 2019-12
Data Sharing
- IPD Sharing
- Will not share